Health Affairs, 23, no. 3 (2004): 269-276 doi: 10.1377/hlthaff.23.3.269 © 2004 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Abstract Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Morgan, S. Articles by Mintzes, B. Search for Related Content PubMed PubMed Citation Articles by Morgan, S. Articles by Mintzes, B. Related Collections Access To Care Health Reform International Issues Business Of Health Pharmaceuticals Health Spending

Outcomes-Based Drug Coverage in British Columbia

View larger version (32K): [in a new window]   EXHIBIT 1 Total (Private And Public) Spending On COX-2 Inhibitors And Other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Purchased Per Capita Per Quarter, In British Columbia And The Rest Of Canada, 1998–2002

View larger version (30K): [in a new window]   EXHIBIT 2 Total Defined Daily Doses (DDDs) Of COX-2 Inhibitors And Other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Purchased Per Capita Per Quarter, In British Columbia And The Rest Of Canada, 1998–2002

                      What's this?